OnKure Therapeutics (OKUR) EPS (Basic) (2020 - 2026)
OnKure Therapeutics' (OKUR) quarterly EPS (Basic) came in at -$1.15 in Q1 2026, up 9.73% YoY from -$1.05 in Q1 2025, and down 9.17% on a QoQ basis from -$1.06 in Q4 2025.
OnKure Therapeutics (OKUR) EPS (Basic) (2020 - 2026) Analysis & Trends
OnKure Therapeutics (OKUR) has 7 years of EPS (Basic) data on file, last reported at -$1.15 in Q1 2026.
- Quarterly EPS (Basic) rose 9.73% year-over-year to -$1.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.64 (up 0.94% YoY) and the FY2025 annual result came in at -$4.7, up 88.85% from the prior year.
- EPS (Basic) eased to -$1.15 in Q1 2026, from -$1.06 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $6.92 in Q4 2023 to a low of -$11.85 in Q3 2023.
- A 5-year average of -$4.31 and a median of -$4.55 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) jumped 215.53% — and 2024, when it slumped 179.3%.
- Tracing OKUR's EPS (Basic) over 5 years: stood at -$5.99 in 2022, then jumped by 215.53% to $6.92 in 2023, then slumped by 179.3% to -$5.48 in 2024, then surged by 80.75% to -$1.06 in 2025, then slipped by 9.17% to -$1.15 in 2026.
- The last three EPS (Basic) figures came in at -$1.15 (Q1 2026), -$1.06 (Q4 2025), and -$1.2 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | 0.18 |
| 10 | OnKure Therapeutics | 196.63 Mn | 20.25 Mn | - | -0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.36 |
| Mar 31, 2026 | -1.15 |
| Dec 31, 2025 | -1.06 |
| Sep 30, 2025 | -1.20 |
| Jun 30, 2025 | -1.27 |
| Mar 31, 2025 | -1.28 |
| Dec 31, 2024 | -5.48 |
| Sep 30, 2024 | -3.47 |
| Jun 30, 2024 | -4.55 |
| Mar 31, 2024 | -2.96 |
| Dec 31, 2023 | 6.92 |
| Sep 30, 2023 | -11.85 |
| Jun 30, 2023 | -11.60 |
| Mar 31, 2023 | -11.18 |
| Dec 31, 2022 | -5.99 |
| Sep 30, 2022 | -5.95 |
| Jun 30, 2022 | -5.74 |
| Mar 31, 2022 | -5.48 |
| Dec 31, 2021 | -13.31 |
| Sep 30, 2021 | -8.86 |